Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Healthcare Industry News Inside Galderma’s blockbuster Q3: Why EQT cashed out CHF690m amid record dermatology growth Find out why EQT exited CHF 690 million in Galderma shares as the dermatology major raised full-year growth guidance after strong Q3 results. bySrinathOctober 31, 2025